1
|
Janda JM, Duman M. Expanding the Spectrum of Diseases and Disease Associations Caused by Edwardsiella tarda and Related Species. Microorganisms 2024; 12:1031. [PMID: 38792860 PMCID: PMC11124366 DOI: 10.3390/microorganisms12051031] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/29/2024] [Revised: 05/12/2024] [Accepted: 05/16/2024] [Indexed: 05/26/2024] Open
Abstract
The genus Edwardsiella, previously residing in the family Enterobacteriaceae and now a member of the family Hafniaceae, is currently composed of five species, although the taxonomy of this genus is still unsettled. The genus can primarily be divided into two pathogenic groups: E. tarda strains are responsible for almost all human infections, and two other species (E. ictaluri, E. piscicida) cause diseases in fish. Human infections predominate in subtropical habitats of the world and in specific geospatial regions with gastrointestinal disease, bloodborne infections, and wound infections, the most common clinical presentations in decreasing order. Gastroenteritis can present in many different forms and mimic other intestinal disturbances. Chronic gastroenteritis is not uncommon. Septicemia is primarily found in persons with comorbid conditions including malignancies and liver disease. Mortality rates range from 9% to 28%. Most human infections are linked to one of several risk factors associated with freshwater or marine environments such as seafood consumption. In contrast, edwardsiellosis in fish is caused by two other species, in particular E. ictaluri. Both E. ictaluri and E. piscicida can cause massive outbreaks of disease in aquaculture systems worldwide, including enteric septicemia in channel catfish and tilapia. Collectively, these species are increasingly being recognized as important pathogens in clinical and veterinary medicine. This article highlights and provides a current perspective on the taxonomy, microbiology, epidemiology, and pathogenicity of this increasingly important group.
Collapse
Affiliation(s)
- J. Michael Janda
- Kern County Public Health Laboratory, Bakersfield, CA 93306, USA
| | - Muhammed Duman
- Aquatic Animal Disease Department, Faculty of Veterinary Medicine, Bursa Uludag University, 16059 Bursa, Turkey;
| |
Collapse
|
2
|
Caira M, Candoni A, Verga L, Busca A, Delia M, Nosari A, Caramatti C, Castagnola C, Cattaneo C, Fanci R, Chierichini A, Melillo L, Mitra ME, Picardi M, Potenza L, Salutari P, Vianelli N, Facchini L, Cesarini M, De Paolis MR, Di Blasi R, Farina F, Venditti A, Ferrari A, Garzia M, Gasbarrino C, Invernizzi R, Lessi F, Manna A, Martino B, Nadali G, Offidani M, Paris L, Pavone V, Rossi G, Spadea A, Specchia G, Trecarichi EM, Vacca A, Cesaro S, Perriello V, Aversa F, Tumbarello M, Pagano L. Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study). Haematologica 2015; 100:284-92. [PMID: 25638805 DOI: 10.3324/haematol.2014.113399] [Citation(s) in RCA: 62] [Impact Index Per Article: 6.9] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022] Open
Abstract
Correct definition of the level of risk of invasive fungal infections is the first step in improving the targeting of preventive strategies. We investigated the potential relationship between pre-hospitalization exposure to sources of fungi and the development of invasive fungal infections in adult patients with newly diagnosed acute myeloid leukemia after their first course of chemotherapy. From January 2010 to April 2012, all consecutive acute myeloid leukemia patients in 33 Italian centers were prospectively registered. Upon first admission, information about possible pre-chemotherapy risk factors and environmental exposure was collected. We recorded data regarding comorbid conditions, employment, hygienic habits, working and living environment, personal habits, hobbies, and pets. All invasive fungal infections occurring within 30 days after the first course of chemotherapy were recorded. Of the 1,192 patients enrolled in this study, 881 received intensive chemotherapy and were included in the present analysis. Of these, 214 developed an invasive fungal infection, including 77 proven/probable cases (8.7%). Of these 77 cases, 54 were proven/probable invasive mold infections (6.1%) and 23 were proven yeast infections (2.6%). Upon univariate analysis, a significant association was found between invasive mold infections and age, performance status, diabetes, chronic obstructive pulmonary disease, smoking, cocaine use, job, hobbies, and a recent house renovation. Higher body weight resulted in a reduced risk of invasive mold infections. Multivariate analysis confirmed the role of performance status, job, body weight, chronic obstructive pulmonary disease, and house renovation. In conclusion, several hospital-independent variables could potentially influence the onset of invasive mold infections in patients with acute myeloid leukemia. Investigation of these factors upon first admission may help to define a patient's risk category and improve targeted prophylactic strategies. (Clinicaltrial.gov: NCT01315925)
Collapse
Affiliation(s)
- Morena Caira
- Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma
| | - Anna Candoni
- Clinica Ematologica, Azienda Ospedaliero Universitaria di Udine
| | - Luisa Verga
- Unità di Ematologia, Università Milano Bicocca, Ospedale S.Gerardo, Monza
| | | | - Mario Delia
- Hematology and BMT Unit, Department of Emergency and Organ Transplantation, University of Bari, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
| | - Annamaria Nosari
- Divisione di Ematologia e Centro Trapianti Midollo, Ospedale Niguarda Ca' Granda, Milan
| | | | - Carlo Castagnola
- Dipartimento Onco-Ematologico Fondazione ICRRS Policlinico San Matteo, Pavia
| | | | - Rosa Fanci
- Unità Funzionale di Ematologia, Azienda Ospedaliero-Universitaria Careggi e Università di Firenze
| | | | - Lorella Melillo
- Unità di Ematologia, IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo
| | | | - Marco Picardi
- Azienda Ospedaliera Universitaria Federico II Napoli, Dipartimento di Medicina Clinica e Chirurgia
| | - Leonardo Potenza
- Sezione di Ematologia, Dipartimento di Scienze Mediche e Chirurgiche Materno-Infantili e dell'Adulto, Università di Modena e Reggio Emilia
| | | | - Nicola Vianelli
- Istituto di Ematologia ed Oncologia Clinica "Lorenzo e Ariosto Serágnoli", Ospedale S.Orsola-Malpighi, Università di Bologna
| | - Luca Facchini
- Divisione di Ematologia, Arciospedale S.Maria Nuova, Reggio Emilia
| | - Monica Cesarini
- Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma
| | | | - Roberta Di Blasi
- Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma
| | - Francesca Farina
- Unità di Ematologia, Università Milano Bicocca, Ospedale S.Gerardo, Monza
| | - Adriano Venditti
- Ematologia, Dipartimento di Biomedicina e Prevenzione, Università Tor Vergata, Roma
| | | | | | | | - Rosangela Invernizzi
- Dipartimento di Medicina Interna, Università di Pavia, Fondazione IRCCS Policlinico San Matteo, Pavia
| | - Federica Lessi
- Ematologia ed Immunologia Clinica, Dipartimento di Medicina, Universita' di Padova
| | | | - Bruno Martino
- Divisione di Ematologia, Azienda Ospedaliera "Bianchi Melacrino Morelli", Reggio Calabria
| | - Gianpaolo Nadali
- UOC Ematologia, Azienda Ospedaliera Universitaria Integrata di Verona
| | | | - Laura Paris
- Divisione di Ematologia e Centro Trapianti Midollo, Ospedale Niguarda Ca' Granda, Milan
| | | | | | - Antonio Spadea
- Unità di Ematologia, Istituti Fisioterapici Ospitalieri, Roma
| | - Giorgina Specchia
- Hematology and BMT Unit, Department of Emergency and Organ Transplantation, University of Bari, Azienda Ospedaliero-Universitaria Consorziale Policlinico di Bari
| | | | | | - Simone Cesaro
- Emato-Oncologia Pediatrica, Azienda Ospedaliera Universitaria Integrata, Verona
| | - Vincenzo Perriello
- Istituto di Ematologia, Ospedale S. Maria della Misericordia, Università di Perugia, Italy
| | | | - Mario Tumbarello
- Istituto di Malattie Infettive, Università Cattolica del Sacro Cuore, Roma
| | - Livio Pagano
- Istituto di Ematologia, Università Cattolica del Sacro Cuore, Roma
| | | |
Collapse
|
6
|
Per H, Kumandaş S, Gümüş H, Oztürk MK, Coşkun A. Meningitis and subgaleal, subdural, epidural empyema due to Pasteurella multocida. J Emerg Med 2008; 39:35-8. [PMID: 18486411 DOI: 10.1016/j.jemermed.2008.04.008] [Citation(s) in RCA: 20] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/06/2005] [Revised: 08/09/2006] [Accepted: 11/10/2006] [Indexed: 11/30/2022]
Abstract
Pasteurella is a Gram-negative coccobacillus found in 70-90% of oral cavities of cats, and as well, is isolated from the digestive systems of dogs, rats, rabbits, monkeys, and other animals. Pasteurella multocida has been known to cause infections in humans, the most familiar being soft tissue infection after animal bites. However, this organism may affect a variety of systems, causing serious disease. Pasteurella multocida can cause septic arthritis, osteomyelitis, pneumonia, endocarditis, meningitis, and septicemia. We report a case of bacterial meningitis, subgaleal, subdural, and epidural empyema due to Pasteurella multocida by a rabbit licking that resulted in neurological complications and a prolonged recovery period.
Collapse
Affiliation(s)
- Hüseyin Per
- Department of Pediatric Neurology, Erciyes University Medical Faculty, Kayseri, Turkey
| | | | | | | | | |
Collapse
|
7
|
Spencer JD, Hastings MC, Rye AK, English BK, Ault BH. Gastroenteritis caused by Edwardsiella tarda in a pediatric renal transplant recipient. Pediatr Transplant 2008; 12:238-41. [PMID: 18086238 DOI: 10.1111/j.1399-3046.2007.00869.x] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Abstract
Edwardsiella tarda, a member of the family Enterobacteriaceae, is a Gram-negative bacillus that is most often pathogenic in aquatic environments. Human infections with Edwardsiella are rare, with most occurring in immunocompromised or immunosuppressed hosts. Reported infections include meningitis, cholecystitis, endocarditis, osteomyelitis, soft tissue infections, bacteremia and septicemia, dysentery, and gastroenteritis. This report describes a case of E. tarda gastroenteritis in a renal transplant patient receiving immunosuppressive therapy. The epidemiology, diagnosis, clinical presentation, and treatment options pertaining to E. tarda infections are examined.
Collapse
Affiliation(s)
- John David Spencer
- Department of Pediatrics, The University of Tennessee Health Sciences Center, Memphis, TN, USA
| | | | | | | | | |
Collapse
|